US Patent Issued to REGENERON PHARMACEUTICALS on Feb. 10 for "Anti-met antibodies, bispecific antigen binding molecules that bind met, and methods of use thereof" (New York, New Jersey Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,735, issued on Feb. 10, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Anti-met antibodies, bispecific antigen binding molecules that bind met, and methods of use thereof" was invented by Robert Babb (River Edge, N.J.), Gang Chen (Yorktown Heights, N.Y.), Christopher Daly (New York), John DaSilva (Somers, N.Y.), Douglas MacDonald (New York) and Thomas Nittoli (Pearl River, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies and bispecific antigen-binding molecules that bind MET and methods of use thereof. The bispecific antigen-binding molecules comprise a first and a second antigen-binding domain, ...